Market revenue in 2023 | USD 70.2 million |
Market revenue in 2030 | USD 113.0 million |
Growth rate | 7% (CAGR from 2023 to 2030) |
Largest segment | Echocardiography |
Fastest growing segment | Radionuclide cardiac imaging |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radionuclide cardiac imaging, Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging |
Key market players worldwide | Toshiba Corporation, Hologic Inc, Carestream Health - HCIS business, GE HealthCare Technologies Inc Common Stock, Siemens Healthineers AG ADR, Koninklijke Philips NV, Hitachi Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive coronary imaging market will help companies and investors design strategic landscapes.
Echocardiography was the largest segment with a revenue share of 30.06% in 2023. Horizon Databook has segmented the North America non-invasive coronary imaging market based on radionuclide cardiac imaging, echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging covering the revenue growth of each sub-segment from 2018 to 2030.
North America held the largest share of this market in 2023 and is expected to grow at a significant rate during the forecast period. The ease of access to healthcare technologies, surge in healthcare expenditure, and presence of strong distribution channels are among the factors contributing to the increasing adoption of non-PVC IV bags in the region.
High disease prevalence, supportive reimbursement policies, and a well-defined regulatory framework are further expected to boost the adoption of non-PVC IV bags in the region. Furthermore, rising adoption of novel drug delivery systems and technological advancements are expected to fuel market growth in this region.
In addition, owing to environmental damage due to PVC bags, efforts are being undertaken by the FDA to encourage the adoption of alternatives to Polyvinyl Chloride (PVC) bags, which is expected to boost the adoption of non-PVC IV bags in the region. Thus, market players in this region are making efforts to adhere to the FDA guidelines to eliminate the usage of PVC bags.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America non-invasive coronary imaging market , including forecasts for subscribers. This continent databook contains high-level insights into North America non-invasive coronary imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account